IDXX vs A
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
IDXX · IDEXX Laboratories Inc$676.04 ▲ 0.79%
A · Agilent Technologies$174.76 ▲ 1.73%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- IDXX -4.7%
- A +20.1%
Head to head
| Metric | IDXX | A |
|---|---|---|
| Price | $676.04 | $174.76 |
| Change today | ▲ 0.79% | ▲ 1.73% |
| Market cap | $53.26B | $49.27B |
| Return, 3 months | +13.5% | +17.5% |
| Return, year to date | -0.1% | +29.2% |
| Return, 1 year | -4.6% | +19.8% |
| P/E (TTM) | 45.6 | 34.5 |
| P/B | 28.5 | 6.7 |
| P/E percentile vs own 5y | 34th | 86th |
| Dividend yield | – | 0.58% |
| Revenue growth (YoY, latest qtr) | +9.7% | +8.1% |
| Net profit growth (YoY) | +15.1% | +7.7% |
| Gross margin | 62.4% | 53.8% |
| Operating margin | 32.0% | 22.2% |
| Net margin | 25.0% | 19.5% |
| Return on equity | 74.2% | 21.0% |
| Analyst target vs. price | +8.1% | +6.4% |
| Analyst buy share | 70% | 86% |
| RSI (14) | 71 | 53 |
| 30-day volatility | 64.7% | 27.7% |
| Max drawdown, 1 year | -34.2% | -29.8% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- IDXX is the largest of the group by market value.
- A has returned the most over the past year.
- A carries the lowest trailing P/E.
- IDXX is growing revenue fastest.
- IDXX keeps the most profit per dollar of sales.
- A has been the calmest stock over the last 30 days.